Last reviewed · How we verify
NCT07216209
The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
NA trial testing EXERCISE TRAINING WITH OR WITHOUT MEDICATION in Lung Cancer - Non Small Cell in 48 participants. Not yet recruiting.
15 January 2030
Quick facts
| Lead sponsor | University of Arizona |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 48 |
| Start date | 20 November 2025 |
| Primary completion | 15 January 2030 |
| Estimated completion | 15 January 2030 |
| Sites | 1 location across United States |
Drugs / interventions tested
- EXERCISE TRAINING WITH OR WITHOUT MEDICATION — full drug profile →
Conditions studied
- Lung Cancer - Non Small Cell — all drugs for Lung Cancer - Non Small Cell →
Sponsor
University of Arizona
Who can join
18 and older, any sex, with Lung Cancer - Non Small Cell. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is increased interest and knowledge about the lung cancer tumor microenvironment (TME). Investigators hypothesize that patients with better baseline physiologic health will have better post-operative outcomes and that strenuous exercise will alter the TME and genetic make-up of the tumor, improving the tumor immune response. Investigators aim to identify the peri-operative and clinical outcomes that differ based on pre-operative VO2max, HRV and resting heart rate following resection of early-stage lung cancer. The physiologic states that are individual and measurable with wearable devices include but are not limited to VO2max, heart rate variability (HRV), and average resting heart rate. Investgators hypothesize that a patient's pre-operative physiologic function with higher VO2max, HRV and lower resting heart rate will be associated with improved peri-operative and post-operative outcomes. Second, investigators will compare alterations in TME based on targeted pre-operative exercise (60-80% of their VO2 max for 75min/week x2 weeks) compared to normal activity adults following resection of early-stage lung cancer. Investigators hypothesize that strenuous exercise in the pre-operative period will impact the TME by increasing levels of cytokines.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07216209
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of EXERCISE TRAINING WITH OR WITHOUT MEDICATION
Trials testing the same drug.
- NCT07452094 — What is the Role of Type III/IV Muscle Afferents in Airway Resistance and Thermoregulatory Responses to Exercise? · EARLY_PHASE1 · not yet recruiting
- NCT07387757 — Exergames in Mental Health · NA · not yet recruiting
- NCT07244562 — Effects of Physical Exercise and Cognitive Training on Quality of Life in Older Women · NA · not yet recruiting
- NCT07244536 — Effects of Physical Exercise and Cognitive Training on Quality of Life in Elderly Adults · NA · recruiting
- NCT07182955 — Determinants of Cardiorespiratory Fitness and Effects of HIIT in Patients With ANOCA Obstructive Coronary Artery Disease · NA · recruiting
Other recruiting trials for Lung Cancer - Non Small Cell
Currently open trials in the same condition.
- NCT06926790 — Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3) · Phase 2 · recruiting
- NCT06889467 — Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer · recruiting
- NCT06659458 — Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients · recruiting
Other University of Arizona trials
Trials by the same sponsor.
- NCT04062890 — Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance · Phase 2 · withdrawn
- NCT05569486 — Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain · NA · not yet recruiting
- NCT05064111 — Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy · suspended
- NCT06567899 — Mechanistic Underpinnings of Preeclampsia · not yet recruiting
- NCT07254793 — Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07216209 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Arizona
- Last refreshed: 22 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07216209.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing